Scaling of Cmin [Regulatives / Guidelines]

posted by Dr_Dan  – Germany, 2014-12-10 18:21 (3798 d 02:34 ago) – Posting: # 14049
Views: 14,908

Dear kumarnaidu

❝ That means we have to use the 4 way (Fully replicate) method here but with a different sequence RRTT or TTRR


No, you do not need to use a 4 period replicate design: You will have 2 periods and 2 sequences, you just need to dose until you reach steady state, take then the PK profile for the dosing interval and after an afreshed dosing for the consecutive interval.

e.g.:
1st dosing drug1
2nd dosing drug1
3rd dosing drug1
4th dosing drug1
5th dosing drug1 -> PK Profile
6th dosing drug1 -> PK Profile
1st dosing drug2
2nd dosing drug2
3rd dosing drug2
4th dosing drug2
5th dosing drug2 -> PK Profile
6th dosing drug2 -> PK Profile


Kind regards
Dr_Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,667 registered users;
70 visitors (0 registered, 70 guests [including 5 identified bots]).
Forum time: 21:55 CEST (Europe/Vienna)

Patients may recover in spite of drugs or because of them.    John Gaddum

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5